Mezoo Co Ltd

Mezoo Co Ltd maintains a strong liquidity position with a current ratio of 3.36, indicating the company can cover its short-term obligations more than three times over. However, the company has a negative net cash position after subtracting total debt, which raises liquidity concerns. The debt-to-equity ratio of 0.3 suggests a conservative capital structure, with equity financing playing a dominant role in the company's operations. The company's profitability is mixed. While it reports a net income of KRW 2,759,611,140, it also shows an operating loss of KRW -2,832,462,140, indicating significant non-operating income or gains. The return on equity of 27.62% is strong, but the return on assets of 19.77% is lower, suggesting that asset utilization is not as efficient as equity returns. Mezoo Co Ltd's revenue is concentrated in a single business segment focused on wearable patient monitoring devices and related software. There is no disclosed geographic diversification, and the company's operations are primarily based in South Korea. This concentration increases exposure to regional economic and regulatory risks. The company's growth trajectory is uncertain. While it has a free cash flow of KRW 2,718,205,430, the operating cash flow is negative at KRW -5,388,631,350, indicating that core operations are not generating sufficient cash. Capital expenditures are relatively low at KRW -387,274,710, suggesting limited investment in expansion or new projects. Risk factors include the company's negative operating cash flow and reliance on non-operating income to fund operations. The risk assessment indicates a medium liquidity risk and low dilution risk, but the negative net cash position after debt is a red flag. No dilution sources are disclosed, and the company has not made any recent equity issuances or shelf offerings. Recent events include the company's continued focus on wearable medical devices and software integration. No major regulatory changes or significant business developments have been disclosed in the latest financial filings. The company remains in a growth phase, but its financial performance is inconsistent.